| 0002-4182 |
Olumiant |
baricitinib |
Eli Lilly and Company |
TABLET, FILM COATED |
|
2018-05-31 |
| 0002-4479 |
Olumiant |
baricitinib |
Eli Lilly and Company |
TABLET, FILM COATED |
|
2022-05-10 |
| 0002-4483 |
Verzenio |
abemaciclib |
Eli Lilly and Company |
TABLET |
|
2017-09-28 |
| 0002-4732 |
Olumiant |
baricitinib |
Eli Lilly and Company |
TABLET, FILM COATED |
|
2019-10-08 |
| 0002-4815 |
Verzenio |
abemaciclib |
Eli Lilly and Company |
TABLET |
|
2017-09-28 |
| 0002-5337 |
Verzenio |
abemaciclib |
Eli Lilly and Company |
TABLET |
|
2017-09-28 |
| 0002-6216 |
Verzenio |
abemaciclib |
Eli Lilly and Company |
TABLET |
|
2017-09-28 |
| 0002-6885 |
Baricitinib |
baricitinib |
Eli Lilly and Company |
TABLET, FILM COATED |
|
2021-12-20 |
| 0002-6902 |
JAYPIRCA |
pirtobrutinib |
Eli Lilly and Company |
TABLET, COATED |
|
2023-01-27 |
| 0002-7026 |
JAYPIRCA |
pirtobrutinib |
Eli Lilly and Company |
TABLET, COATED |
|
2023-01-27 |
| 0008-1041 |
Rapamune |
SIROLIMUS |
Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. |
TABLET, SUGAR COATED |
|
2001-07-01 |
| 0008-1042 |
Rapamune |
SIROLIMUS |
Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. |
TABLET, SUGAR COATED |
|
2001-07-01 |
| 0054-0470 |
Everolimus |
Everolimus |
Hikma Pharmaceuticals USA Inc. |
TABLET |
|
2020-03-10 |
| 0054-0471 |
Everolimus |
Everolimus |
Hikma Pharmaceuticals USA Inc. |
TABLET |
|
2020-03-10 |
| 0054-0472 |
Everolimus |
Everolimus |
Hikma Pharmaceuticals USA Inc. |
TABLET |
|
2020-03-10 |
| 0054-0480 |
Everolimus |
Everolimus |
Hikma Pharmaceuticals USA Inc. |
TABLET |
|
2020-06-08 |
| 0054-0481 |
Everolimus |
Everolimus |
Hikma Pharmaceuticals USA Inc. |
TABLET |
|
2020-06-08 |
| 0054-0482 |
Everolimus |
Everolimus |
Hikma Pharmaceuticals USA Inc. |
TABLET |
|
2020-06-08 |
| 0054-0497 |
Everolimus |
Everolimus |
Hikma Pharmaceuticals USA Inc. |
TABLET |
|
2020-06-08 |
| 0054-0604 |
Everolimus |
Everolimus |
Hikma Pharmaceuticals USA Inc. |
TABLET |
|
2021-11-18 |
| 0069-0145 |
INLYTA |
axitinib |
Pfizer Laboratories Div Pfizer Inc |
TABLET, FILM COATED |
|
2012-01-27 |
| 0069-0151 |
INLYTA |
axitinib |
Pfizer Laboratories Div Pfizer Inc |
TABLET, FILM COATED |
|
2012-01-27 |
| 0069-0187 |
Ibrance |
palbociclib |
Pfizer Laboratories Div Pfizer Inc |
CAPSULE |
|
2015-02-03 |
| 0069-0188 |
Ibrance |
palbociclib |
Pfizer Laboratories Div Pfizer Inc |
CAPSULE |
|
2015-02-03 |
| 0069-0189 |
Ibrance |
palbociclib |
Pfizer Laboratories Div Pfizer Inc |
CAPSULE |
|
2015-02-03 |
| 0069-0227 |
Lorbrena |
lorlatinib |
Pfizer Laboratories Div Pfizer Inc |
TABLET, FILM COATED |
|
2018-11-19 |
| 0069-0231 |
Lorbrena |
lorlatinib |
Pfizer Laboratories Div Pfizer Inc |
TABLET, FILM COATED |
|
2018-11-19 |
| 0069-0235 |
Cibinqo |
abrocitinib |
Pfizer Laboratories Div Pfizer Inc |
TABLET, FILM COATED |
|
2022-02-24 |
| 0069-0251 |
Xalkori |
CRIZOTINIB |
Pfizer Laboratories Div Pfizer Inc |
CAPSULE, COATED PELLETS |
|
2023-11-20 |
| 0069-0284 |
Ibrance |
palbociclib |
Pfizer Laboratories Div Pfizer Inc |
TABLET, FILM COATED |
|
2020-03-30 |
| 0069-0335 |
Cibinqo |
abrocitinib |
Pfizer Laboratories Div Pfizer Inc |
TABLET, FILM COATED |
|
2022-02-24 |
| 0069-0435 |
Cibinqo |
abrocitinib |
Pfizer Laboratories Div Pfizer Inc |
TABLET, FILM COATED |
|
2022-02-24 |
| 0069-0486 |
Ibrance |
palbociclib |
Pfizer Laboratories Div Pfizer Inc |
TABLET, FILM COATED |
|
2020-03-30 |
| 0069-0507 |
Xalkori |
CRIZOTINIB |
Pfizer Laboratories Div Pfizer Inc |
CAPSULE, COATED PELLETS |
|
2023-11-20 |
| 0069-0688 |
Ibrance |
palbociclib |
Pfizer Laboratories Div Pfizer Inc |
TABLET, FILM COATED |
|
2020-03-30 |
| 0069-1500 |
Xalkori |
CRIZOTINIB |
Pfizer Laboratories Div Pfizer Inc |
CAPSULE, COATED PELLETS |
|
2023-11-20 |
| 0069-8140 |
Xalkori |
CRIZOTINIB |
Pfizer Laboratories Div Pfizer Inc |
CAPSULE |
|
2011-08-26 |
| 0069-8141 |
Xalkori |
CRIZOTINIB |
Pfizer Laboratories Div Pfizer Inc |
CAPSULE |
|
2011-08-26 |
| 0074-1043 |
Rinvoq |
Upadacitinib |
AbbVie Inc. |
TABLET, EXTENDED RELEASE |
|
2019-08-16 |
| 0074-2306 |
Rinvoq |
Upadacitinib |
AbbVie Inc. |
TABLET, EXTENDED RELEASE |
|
2019-08-16 |
| 0074-2310 |
Rinvoq |
Upadacitinib |
AbbVie Inc. |
TABLET, EXTENDED RELEASE |
|
2019-08-16 |
| 0074-2320 |
Rinvoq |
Upadacitinib |
AbbVie Inc. |
SOLUTION |
|
2024-04-26 |
| 0078-0414 |
Zortress |
everolimus |
Novartis Pharmaceuticals Corporation |
TABLET |
|
2010-04-22 |
| 0078-0415 |
Zortress |
everolimus |
Novartis Pharmaceuticals Corporation |
TABLET |
|
2010-04-22 |
| 0078-0417 |
Zortress |
everolimus |
Novartis Pharmaceuticals Corporation |
TABLET |
|
2010-04-22 |
| 0078-0422 |
Zortress |
everolimus |
Novartis Pharmaceuticals Corporation |
TABLET |
|
2010-04-22 |
| 0078-0566 |
Afinitor |
everolimus |
Novartis Pharmaceuticals Corporation |
TABLET |
|
2009-03-31 |
| 0078-0567 |
Afinitor |
everolimus |
Novartis Pharmaceuticals Corporation |
TABLET |
|
2009-03-31 |
| 0078-0594 |
Afinitor |
everolimus |
Novartis Pharmaceuticals Corporation |
TABLET |
|
2010-07-09 |
| 0078-0620 |
Afinitor |
everolimus |
Novartis Pharmaceuticals Corporation |
TABLET |
|
2011-07-29 |
| 0078-0626 |
Afinitor Disperz |
everolimus |
Novartis Pharmaceuticals Corporation |
TABLET, FOR SUSPENSION |
|
2012-08-29 |
| 0078-0627 |
Afinitor Disperz |
everolimus |
Novartis Pharmaceuticals Corporation |
TABLET, FOR SUSPENSION |
|
2012-08-29 |
| 0078-0628 |
Afinitor Disperz |
everolimus |
Novartis Pharmaceuticals Corporation |
TABLET, FOR SUSPENSION |
|
2012-08-29 |
| 0078-0694 |
ZYKADIA |
ceritinib |
Novartis Pharmaceuticals Corporation |
TABLET, FILM COATED |
|
2019-03-18 |
| 0078-0698 |
RYDAPT |
RYDAPT |
Novartis Pharmaceuticals Corporation |
CAPSULE, LIQUID FILLED |
|
2017-04-28 |
| 0093-7766 |
Everolimus |
Everolimus |
Teva Pharmaceuticals USA, Inc. |
TABLET |
|
2020-06-10 |
| 0093-7767 |
Everolimus |
Everolimus |
Teva Pharmaceuticals USA, Inc. |
TABLET |
|
2020-06-10 |
| 0093-7768 |
Everolimus |
Everolimus |
Teva Pharmaceuticals USA, Inc. |
TABLET |
|
2020-06-10 |
| 0093-7769 |
Everolimus |
Everolimus |
Teva Pharmaceuticals USA, Inc. |
TABLET |
|
2023-10-23 |
| 0245-0822 |
TORPENZ |
Everolimus |
Upsher-Smith Laboratories, LLC |
TABLET |
|
2021-10-01 |
| 0245-0823 |
TORPENZ |
Everolimus |
Upsher-Smith Laboratories, LLC |
TABLET |
|
2021-10-01 |
| 0245-0824 |
TORPENZ |
Everolimus |
Upsher-Smith Laboratories, LLC |
TABLET |
|
2021-10-01 |
| 0245-0825 |
TORPENZ |
Everolimus |
Upsher-Smith Laboratories, LLC |
TABLET |
|
2021-10-01 |
| 0310-0482 |
IRESSA |
Gefitinib |
AstraZeneca Pharmaceuticals LP |
TABLET, COATED |
|
2015-07-13 |
| 0310-1248 |
TAGRISSO |
osimertinib |
AstraZeneca Pharmaceuticals LP |
TABLET, FILM COATED |
|
2015-11-13 |
| 0310-1251 |
TAGRISSO |
osimertinib |
AstraZeneca Pharmaceuticals LP |
TABLET, FILM COATED |
|
2015-11-13 |
| 0310-1349 |
TAGRISSO |
osimertinib |
AstraZeneca Pharmaceuticals LP |
TABLET, FILM COATED |
|
2015-11-13 |
| 0310-1350 |
TAGRISSO |
osimertinib |
AstraZeneca Pharmaceuticals LP |
TABLET, FILM COATED |
|
2015-11-13 |
| 0310-3512 |
CALQUENCE |
acalabrutinib |
AstraZeneca Pharmaceuticals LP |
TABLET, FILM COATED |
|
2022-08-04 |
| 0310-4513 |
CALQUENCE |
acalabrutinib |
AstraZeneca Pharmaceuticals LP |
TABLET, FILM COATED |
|
2022-08-04 |
| 0378-0005 |
Everolimus |
Everolimus |
Mylan Pharmaceuticals Inc. |
TABLET, FOR SUSPENSION |
|
2021-10-01 |
| 0378-0006 |
Everolimus |
Everolimus |
Mylan Pharmaceuticals Inc. |
TABLET, FOR SUSPENSION |
|
2021-10-01 |
| 0378-0007 |
Everolimus |
Everolimus |
Mylan Pharmaceuticals Inc. |
TABLET, FOR SUSPENSION |
|
2021-10-01 |
| 0480-4053 |
Gefitinib |
Gefitinib |
Teva Pharmaceuticals, Inc. |
TABLET, FILM COATED |
|
2023-06-21 |
| 0597-0137 |
Gilotrif |
afatinib |
Boehringer Ingelheim Pharmaceuticals, Inc. |
TABLET, FILM COATED |
|
2013-07-12 |
| 0597-0138 |
Gilotrif |
afatinib |
Boehringer Ingelheim Pharmaceuticals, Inc. |
TABLET, FILM COATED |
|
2013-07-12 |
| 0597-0141 |
Gilotrif |
afatinib |
Boehringer Ingelheim Pharmaceuticals, Inc. |
TABLET, FILM COATED |
|
2013-07-12 |
| 0904-7248 |
Sirolimus |
Sirolimus |
Major Pharmaceuticals |
TABLET |
|
2021-03-13 |
| 13668-682 |
Sorafenib |
sorafenib |
Torrent Pharmaceuticals Limited |
TABLET, FILM COATED |
|
2023-04-12 |
| 16571-806 |
Sirolimus |
Sirolimus |
Rising Pharma Holdings, Inc. |
SOLUTION |
|
2025-07-15 |
| 16714-187 |
sirolimus |
sirolimus |
NORTHSTAR RX LLC |
TABLET, FILM COATED |
|
2021-10-18 |
| 16714-188 |
sirolimus |
sirolimus |
NORTHSTAR RX LLC |
TABLET, FILM COATED |
|
2021-10-18 |
| 16714-189 |
sirolimus |
sirolimus |
NORTHSTAR RX LLC |
TABLET, FILM COATED |
|
2021-10-18 |
| 24338-154 |
DANZITEN |
nilotinib |
Azurity Pharmaceuticals, Inc. |
TABLET |
|
2024-11-30 |
| 24338-155 |
DANZITEN |
nilotinib |
Azurity Pharmaceuticals, Inc. |
TABLET |
|
2024-11-30 |
| 24979-715 |
sorafenib |
sorafenib |
Upsher-Smith Laboratories, LLC |
TABLET, FILM COATED |
|
2022-12-01 |
| 31722-316 |
SIROLIMUS |
Sirolimus |
Camber Pharmaceuticals, Inc. |
SOLUTION |
|
2024-09-16 |
| 49884-119 |
Everolimus |
Everolimus |
ENDO USA, Inc. |
TABLET |
|
2019-12-10 |
| 49884-125 |
Everolimus |
Everolimus |
ENDO USA, Inc. |
TABLET |
|
2019-12-10 |
| 49884-127 |
Everolimus |
Everolimus |
ENDO USA, Inc. |
TABLET |
|
2019-12-10 |
| 49884-128 |
Everolimus |
Everolimus |
ENDO USA, Inc. |
TABLET |
|
2022-11-29 |
| 49884-158 |
Everolimus |
Everolimus |
Par Health USA, LLC |
TABLET |
|
2022-03-31 |
| 49884-159 |
Everolimus |
Everolimus |
Par Health USA, LLC |
TABLET |
|
2022-03-31 |
| 49884-160 |
Everolimus |
Everolimus |
Par Health USA, LLC |
TABLET |
|
2022-12-16 |
| 49884-283 |
Everolimus |
Everolimus |
Par Health USA, LLC |
TABLET |
|
2022-01-26 |
| 50222-280 |
Anzupgo |
delgocitinib |
LEO Pharma, Inc |
CREAM |
|
2025-07-24 |
| 50242-090 |
ZELBORAF |
Vemurafenib |
Genentech, Inc. |
TABLET, FILM COATED |
|
2011-08-17 |
| 50268-718 |
Sirolimus |
Sirolimus |
AvPAK |
TABLET |
|
2018-04-23 |
| 50419-488 |
Nexavar |
sorafenib |
Bayer HealthCare Pharmaceuticals Inc. |
TABLET, FILM COATED |
|
2005-12-20 |
| 50419-489 |
Nexavar |
sorafenib |
Bayer HealthCare Pharmaceuticals Inc. |
TABLET, FILM COATED |
|
2023-10-02 |
| 50742-366 |
Gefitinib |
Gefitinib |
Ingenus Pharmaceuticals, LLC |
TABLET, COATED |
|
2023-04-27 |
| 50881-005 |
JAKAFI |
ruxolitinib |
Incyte Corporation |
TABLET |
|
2011-11-16 |
| 50881-010 |
JAKAFI |
ruxolitinib |
Incyte Corporation |
TABLET |
|
2011-11-16 |
| 50881-015 |
JAKAFI |
ruxolitinib |
Incyte Corporation |
TABLET |
|
2011-11-16 |
| 50881-020 |
JAKAFI |
ruxolitinib |
Incyte Corporation |
TABLET |
|
2011-11-16 |
| 50881-025 |
JAKAFI |
ruxolitinib |
Incyte Corporation |
TABLET |
|
2011-11-16 |
| 50881-026 |
PEMAZYRE |
pemigatinib |
Incyte Corporation |
TABLET |
|
2020-04-17 |
| 50881-027 |
PEMAZYRE |
pemigatinib |
Incyte Corporation |
TABLET |
|
2020-04-17 |
| 50881-028 |
PEMAZYRE |
pemigatinib |
Incyte Corporation |
TABLET |
|
2020-04-17 |
| 51144-001 |
TUKYSA |
tucatinib |
SEAGEN INC. |
TABLET |
|
2020-04-17 |
| 51144-002 |
TUKYSA |
tucatinib |
SEAGEN INC. |
TABLET |
|
2020-04-17 |
| 51407-760 |
sorafenib |
sorafenib |
Golden State Medical Supply, Inc. |
TABLET, FILM COATED |
|
2022-11-09 |
| 51407-872 |
Pazopanib |
Pazopanib |
Golden State Medical Supply, Inc. |
TABLET |
|
2023-10-19 |
| 51990-201 |
sorafenib |
sorafenib |
Yabao Pharmaceutical Co., Ltd. Beijing |
TABLET, FILM COATED |
|
2022-12-01 |
| 51991-821 |
Everolimus |
Everolimus |
Breckenridge Pharmaceutical, Inc. |
TABLET |
|
2021-03-05 |
| 51991-822 |
Everolimus |
Everolimus |
Breckenridge Pharmaceutical, Inc. |
TABLET |
|
2021-03-05 |
| 51991-823 |
Everolimus |
Everolimus |
Breckenridge Pharmaceutical, Inc. |
TABLET |
|
2021-03-05 |
| 51991-824 |
Everolimus |
Everolimus |
Breckenridge Pharmaceutical, Inc. |
TABLET |
|
2021-03-05 |
| 51991-990 |
Everolimus |
Everolimus |
Breckenridge Pharmaceutical, Inc. |
TABLET, FOR SUSPENSION |
|
2025-01-28 |
| 51991-991 |
Everolimus |
Everolimus |
Breckenridge Pharmaceutical, Inc. |
TABLET, FOR SUSPENSION |
|
2025-01-28 |
| 51991-992 |
Everolimus |
Everolimus |
Breckenridge Pharmaceutical, Inc. |
TABLET, FOR SUSPENSION |
|
2025-01-28 |
| 55111-653 |
Sirolimus |
Sirolimus |
Dr. Reddy's Laboratories Limited |
TABLET |
|
2014-10-27 |
| 55111-654 |
Sirolimus |
Sirolimus |
Dr. Reddy's Laboratories Limited |
TABLET |
|
2014-10-27 |
| 57894-080 |
LAZCLUZE |
lazertinib |
Janssen Biotech, Inc. |
TABLET, FILM COATED |
|
2024-08-20 |
| 57894-240 |
LAZCLUZE |
lazertinib |
Janssen Biotech, Inc. |
TABLET, FILM COATED |
|
2024-08-20 |
| 57962-007 |
Imbruvica |
Ibrutinib |
Pharmacyclics LLC |
SUSPENSION |
|
2022-08-24 |
| 57962-014 |
Imbruvica |
Ibrutinib |
Pharmacyclics LLC |
TABLET, FILM COATED |
|
2018-02-16 |
| 57962-070 |
Imbruvica |
Ibrutinib |
Pharmacyclics LLC |
CAPSULE |
|
2017-12-20 |
| 57962-140 |
Imbruvica |
Ibrutinib |
Pharmacyclics LLC |
CAPSULE |
|
2013-11-13 |
| 57962-280 |
Imbruvica |
Ibrutinib |
Pharmacyclics LLC |
TABLET, FILM COATED |
|
2018-02-16 |
| 57962-420 |
Imbruvica |
Ibrutinib |
Pharmacyclics LLC |
TABLET, FILM COATED |
|
2018-02-16 |
| 58468-7820 |
CAPRELSA |
Vandetanib |
Genzyme Corporation |
TABLET, FILM COATED |
|
2011-07-25 |
| 58468-7840 |
CAPRELSA |
Vandetanib |
Genzyme Corporation |
TABLET, FILM COATED |
|
2011-07-25 |
| 59762-1001 |
Sirolimus |
SIROLIMUS |
Mylan Pharmaceuticals Inc. |
TABLET, SUGAR COATED |
|
2014-01-07 |
| 59762-1002 |
Sirolimus |
SIROLIMUS |
Mylan Pharmaceuticals Inc. |
TABLET, SUGAR COATED |
|
2014-10-27 |
| 59762-1003 |
Sirolimus |
SIROLIMUS |
Mylan Pharmaceuticals Inc. |
TABLET, SUGAR COATED |
|
2014-10-27 |
| 59762-1205 |
Sirolimus |
sirolimus |
Mylan Pharmaceuticals Inc. |
SOLUTION |
|
2019-07-22 |
| 60219-2279 |
EVEROLIMUS |
everolimus |
Amneal Pharmaceuticals NY LLC |
TABLET, FOR SUSPENSION |
|
2025-01-14 |
| 60219-2280 |
EVEROLIMUS |
everolimus |
Amneal Pharmaceuticals NY LLC |
TABLET, FOR SUSPENSION |
|
2025-01-14 |
| 60219-2281 |
EVEROLIMUS |
everolimus |
Amneal Pharmaceuticals NY LLC |
TABLET, FOR SUSPENSION |
|
2025-01-14 |
| 60505-3801 |
Nilotinib |
nilotinib |
Apotex Corp. |
CAPSULE |
|
2025-05-23 |
| 60505-3802 |
Nilotinib |
nilotinib |
Apotex Corp. |
CAPSULE |
|
2025-05-23 |
| 60505-3803 |
Nilotinib |
nilotinib |
Apotex Corp. |
CAPSULE |
|
2025-05-23 |
| 60505-4512 |
Gefitinib |
Gefitinib |
Apotex Corp. |
TABLET |
|
2023-08-08 |
| 60505-4779 |
Pazopanib |
Pazopanib |
Apotex Corp. |
TABLET |
|
2023-10-19 |
| 60505-6197 |
Sirolimus |
SIROLIMUS |
Apotex Corp |
SOLUTION |
|
2020-05-20 |
| 61958-1701 |
Zydelig |
idelalisib |
Gilead Sciences, Inc. |
TABLET, FILM COATED |
|
2014-07-23 |
| 61958-1702 |
Zydelig |
idelalisib |
Gilead Sciences, Inc. |
TABLET, FILM COATED |
|
2014-07-23 |
| 62856-704 |
Lenvima |
Lenvatinib |
Eisai Inc. |
CAPSULE |
|
2018-08-15 |
| 62856-708 |
Lenvima |
Lenvatinib |
Eisai Inc. |
CAPSULE |
|
2016-05-13 |
| 62856-710 |
Lenvima |
Lenvatinib |
Eisai Inc. |
CAPSULE |
|
2015-02-13 |
| 62856-712 |
Lenvima |
Lenvatinib |
Eisai Inc. |
CAPSULE |
|
2018-08-15 |
| 62856-714 |
Lenvima |
Lenvatinib |
Eisai Inc. |
KIT |
|
2015-02-13 |
| 62856-718 |
Lenvima |
Lenvatinib |
Eisai Inc. |
KIT |
|
2016-05-13 |
| 62856-720 |
Lenvima |
Lenvatinib |
Eisai Inc. |
CAPSULE |
|
2015-02-13 |
| 62856-724 |
Lenvima |
Lenvatinib |
Eisai Inc. |
KIT |
|
2015-02-13 |
| 63020-090 |
Alunbrig |
brigatinib |
Takeda Pharmaceuticals America, Inc. |
TABLET, FILM COATED |
|
2017-04-28 |
| 63020-113 |
Alunbrig |
brigatinib |
Takeda Pharmaceuticals America, Inc. |
TABLET, FILM COATED |
|
2017-04-28 |
| 63020-180 |
Alunbrig |
brigatinib |
Takeda Pharmaceuticals America, Inc. |
TABLET, FILM COATED |
|
2017-04-28 |
| 63020-198 |
Alunbrig |
brigatinib |
Takeda Pharmaceuticals America, Inc. |
KIT |
|
2017-04-28 |
| 63304-095 |
Erlotinib |
Erlotinib |
Sun Pharmaceutical Industries, Inc. |
TABLET, FILM COATED |
|
2019-11-05 |
| 63304-096 |
Erlotinib |
Erlotinib |
Sun Pharmaceutical Industries, Inc. |
TABLET, FILM COATED |
|
2019-11-05 |
| 63304-135 |
Erlotinib |
Erlotinib |
Sun Pharmaceutical Industries, Inc. |
TABLET, FILM COATED |
|
2019-11-05 |
| 63539-026 |
INLYTA |
axitinib |
U.S. Pharmaceuticals |
TABLET, FILM COATED |
|
2012-01-27 |
| 63539-044 |
INLYTA |
axitinib |
U.S. Pharmaceuticals |
TABLET, FILM COATED |
|
2012-01-27 |
| 63539-187 |
Ibrance |
palbociclib |
U.S. Pharmaceuticals |
CAPSULE |
|
2017-05-08 |
| 63539-188 |
Ibrance |
palbociclib |
U.S. Pharmaceuticals |
CAPSULE |
|
2017-05-08 |
| 63539-189 |
Ibrance |
palbociclib |
U.S. Pharmaceuticals |
CAPSULE |
|
2015-02-03 |
| 63539-236 |
CIBINQO |
abrocitinib |
U.S. Pharmaceuticals |
TABLET, FILM COATED |
|
2022-02-24 |
| 63539-284 |
Ibrance |
palbociclib |
U.S. Pharmaceuticals |
TABLET, FILM COATED |
|
2020-03-30 |
| 63539-336 |
CIBINQO |
abrocitinib |
U.S. Pharmaceuticals |
TABLET, FILM COATED |
|
2022-02-24 |
| 63539-436 |
CIBINQO |
abrocitinib |
U.S. Pharmaceuticals |
TABLET, FILM COATED |
|
2022-02-24 |
| 63539-486 |
Ibrance |
palbociclib |
U.S. Pharmaceuticals |
TABLET, FILM COATED |
|
2020-03-30 |
| 63539-688 |
Ibrance |
palbociclib |
U.S. Pharmaceuticals |
TABLET, FILM COATED |
|
2020-03-30 |
| 63539-927 |
Lorbrena |
lorlatinib |
U.S. Pharmaceuticals |
TABLET, FILM COATED |
|
2023-01-03 |
| 63850-0058 |
Everolimus |
Everolimus |
Natco Pharma Limited |
TABLET |
|
2021-03-05 |
| 63850-0059 |
Everolimus |
Everolimus |
Natco Pharma Limited |
TABLET |
|
2021-03-05 |
| 63850-0060 |
Everolimus |
Everolimus |
Natco Pharma Limited |
TABLET |
|
2021-03-05 |
| 63850-0061 |
Everolimus |
Everolimus |
Natco Pharma Limited |
TABLET |
|
2021-10-01 |
| 63850-0062 |
Everolimus |
Everolimus |
Natco Pharma Limited |
TABLET |
|
2021-05-20 |
| 63850-0063 |
Everolimus |
Everolimus |
Natco Pharma Limited |
TABLET |
|
2021-05-20 |
| 63850-0064 |
Everolimus |
Everolimus |
Natco Pharma Limited |
TABLET |
|
2021-05-20 |
| 64764-800 |
Livtencity |
MARIBAVIR |
Takeda Pharmaceuticals America, Inc. |
TABLET, COATED |
|
2021-11-23 |
| 65841-771 |
sirolimus |
sirolimus |
Zydus Lifesciences Limited |
TABLET, FILM COATED |
|
2014-01-15 |
| 65841-772 |
sirolimus |
sirolimus |
Zydus Lifesciences Limited |
TABLET, FILM COATED |
|
2023-02-16 |
| 65841-773 |
sirolimus |
sirolimus |
Zydus Lifesciences Limited |
TABLET, FILM COATED |
|
2023-02-16 |
| 66689-347 |
Sirolimus |
Sirolimus |
VistaPharm, LLC |
SOLUTION |
|
2019-01-28 |
| 67184-0531 |
Gefitinib |
Gefitinib |
Qilu Pharmaceutical Co., Ltd. |
TABLET, COATED |
|
2023-02-13 |
| 67877-718 |
Everolimus |
Everolimus |
Ascend Laboratories, LLC |
TABLET |
|
2021-11-27 |
| 67877-719 |
Everolimus |
Everolimus |
Ascend Laboratories, LLC |
TABLET |
|
2021-11-27 |
| 67877-720 |
Everolimus |
Everolimus |
Ascend Laboratories, LLC |
TABLET |
|
2021-11-27 |
| 67877-721 |
Everolimus |
Everolimus |
Ascend Laboratories, LLC |
TABLET |
|
2021-11-27 |
| 67877-746 |
Sirolimus |
Sirolimus |
Ascend Laboratories, LLC |
TABLET |
|
2021-03-13 |
| 67877-747 |
Sirolimus |
Sirolimus |
Ascend Laboratories, LLC |
TABLET |
|
2021-03-13 |
| 67877-748 |
Sirolimus |
Sirolimus |
Ascend Laboratories, LLC |
TABLET |
|
2021-03-13 |
| 68084-915 |
Sirolimus |
Sirolimus |
American Health Packaging |
TABLET |
|
2015-11-05 |
| 68382-351 |
sirolimus |
sirolimus |
Zydus Pharmaceuticals USA Inc. |
TABLET, FILM COATED |
|
2023-02-16 |
| 68382-352 |
sirolimus |
sirolimus |
Zydus Pharmaceuticals USA Inc. |
TABLET, FILM COATED |
|
2023-02-16 |
| 68382-520 |
sirolimus |
sirolimus |
Zydus Pharmaceuticals USA Inc. |
TABLET, FILM COATED |
|
2014-01-15 |
| 68462-682 |
sirolimus |
sirolimus |
Glenmark Pharmaceuticals Inc., USA |
TABLET, FILM COATED |
|
2020-10-16 |
| 68462-683 |
sirolimus |
sirolimus |
Glenmark Pharmaceuticals Inc., USA |
TABLET, FILM COATED |
|
2020-10-16 |
| 68462-684 |
sirolimus |
sirolimus |
Glenmark Pharmaceuticals Inc., USA |
TABLET, FILM COATED |
|
2020-10-16 |
| 69097-030 |
Nilotinib |
Nilotinib |
Cipla USA Inc. |
CAPSULE |
|
2025-06-18 |
| 69097-031 |
Nilotinib |
Nilotinib |
Cipla USA Inc. |
CAPSULE |
|
2025-06-18 |
| 69097-032 |
Nilotinib |
Nilotinib |
Cipla USA Inc. |
CAPSULE |
|
2025-06-18 |
| 69238-1594 |
Sirolimus |
SIrolimus |
Amneal Pharmaceuticals NY LLC |
SOLUTION |
|
2019-10-25 |
| 69339-168 |
Gefitinib |
Gefitinib |
Natco Pharma USA LLC |
TABLET, FILM COATED |
|
2023-06-05 |
| 70377-010 |
EVEROLIMUS |
everolimus |
Biocon Pharma Inc. |
TABLET |
|
2021-10-01 |
| 70377-011 |
EVEROLIMUS |
everolimus |
Biocon Pharma Inc. |
TABLET |
|
2021-10-01 |
| 70377-012 |
EVEROLIMUS |
everolimus |
Biocon Pharma Inc. |
TABLET |
|
2021-10-01 |
| 70377-013 |
EVEROLIMUS |
everolimus |
Biocon Pharma Inc. |
TABLET |
|
2021-10-01 |
| 70377-069 |
Everolimus |
Everolimus |
Biocon Pharma Inc. |
TABLET |
|
2025-06-02 |
| 70377-070 |
Everolimus |
EVEROLIMUS |
Biocon Pharma Inc. |
TABLET |
|
2025-06-02 |
| 70377-071 |
Everolimus |
everolimus |
Biocon Pharma Inc. |
TABLET |
|
2025-06-02 |
| 70377-112 |
Everolimus |
everolimus |
Biocon Pharma Inc. |
TABLET |
|
2025-06-02 |
| 70518-3546 |
Sirolimus |
Sirolimus |
REMEDYREPACK INC. |
TABLET |
|
2022-09-30 |
| 70518-4376 |
sirolimus |
sirolimus |
REMEDYREPACK INC. |
TABLET, FILM COATED |
|
2025-06-28 |
| 70518-4449 |
sirolimus |
sirolimus |
REMEDYREPACK INC. |
TABLET, FILM COATED |
|
2025-08-19 |
| 72064-110 |
Ayvakit |
avapritinib |
Blueprint Medicines Corporation |
TABLET, FILM COATED |
|
2020-01-09 |
| 72064-120 |
Ayvakit |
avapritinib |
Blueprint Medicines Corporation |
TABLET, FILM COATED |
|
2020-01-09 |
| 72064-125 |
Ayvakit |
avapritinib |
Blueprint Medicines Corporation |
TABLET, FILM COATED |
|
2021-06-16 |
| 72064-130 |
Ayvakit |
avapritinib |
Blueprint Medicines Corporation |
TABLET, FILM COATED |
|
2020-01-09 |
| 72064-150 |
Ayvakit |
avapritinib |
Blueprint Medicines Corporation |
TABLET, FILM COATED |
|
2021-06-16 |
| 72205-099 |
sirolimus |
sirolimus |
Novadoz Pharmaceuticals LLC |
SOLUTION |
|
2023-01-19 |
| 72482-100 |
Vonjo |
Pacritinib |
Sobi, Inc. |
CAPSULE |
|
2022-02-28 |
| 72482-100 |
Vonjo |
Pacritinib |
Sobi, Inc. |
CAPSULE |
|
2022-02-28 |
| 72579-011 |
BRUKINSA |
zanubrutinib |
BeOne Medicines USA, Inc. |
CAPSULE |
|
2019-11-14 |
| 72579-122 |
BRUKINSA |
zanubrutinib |
BeOne Medicines USA, Inc. |
TABLET, FILM COATED |
|
2025-08-18 |
| 72603-254 |
EVEROLIMUS |
everolimus |
NorthStar RxLLC |
TABLET |
|
2024-10-01 |
| 72603-255 |
EVEROLIMUS |
everolimus |
NorthStar RxLLC |
TABLET |
|
2024-10-01 |
| 72603-256 |
EVEROLIMUS |
everolimus |
NorthStar RxLLC |
TABLET |
|
2024-10-01 |
| 72603-257 |
EVEROLIMUS |
everolimus |
NorthStar RxLLC |
TABLET |
|
2024-10-01 |
| 72603-409 |
sirolimus |
sirolimus |
Northstar Rx LLC |
SOLUTION |
|
2023-01-19 |
| 73683-101 |
HYFTOR |
sirolimus |
Nobelpharma America, LLC |
GEL |
|
2022-03-23 |
| 80803-153 |
FYARRO |
Sirolimus |
Aadi Bioscience |
INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION |
|
2021-12-06 |
| 82950-001 |
OJEMDA |
TOVORAFENIB |
Day One Biopharmaceuticals, Inc. |
TABLET, FILM COATED |
|
2024-04-30 |
| 82950-012 |
OJEMDA |
tovorafenib |
Day One Biopharmaceuticals, Inc. |
KIT |
|
2024-04-30 |